Lanean...
A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth
Prolactin secreting pituitary adenomas (prolactinomas) is the most common pituitary tumors in humans. Animal studies have identified aggressive prolactinoma development in fetal alcohol exposed rats. We have recently identified a combination treatment of a μ opioid receptor antagonist naltrexone and...
Gorde:
| Argitaratua izan da: | J Cell Commun Signal |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Netherlands
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5559393/ https://ncbi.nlm.nih.gov/pubmed/28144772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-017-0374-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|